Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output
- PMID: 30277207
- PMCID: PMC6283480
- DOI: 10.4269/ajtmh.18-0402
Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output
Abstract
Strongyloides stercoralis is the main etiological agent of human strongyloidiasis. Severe strongyloidiasis is commonly associated to alcoholism, corticostereoid use, and human T cell lymphotropic virus type 1 (HTLV-1) coinfection. Herein, we report a case of a 13-year-old boy coinfected with S. stercoralis and HTLV-1, excreting several parasitic forms in the stool. The parasitological examination of his feces showed a large amount of filariform (about 3,000 larvae per gram of feces) and rhabditiform larvae (about 2,000 larvae per gram of feces). In addition, free-living adult females (about 50 parasites per gram of feces) and eggs (about 60 eggs per gram of feces) were detected. The main laboratory findings pointed to high immunoglobulin E (IgE) levels (228 UI/mL) and eosinophila (11.6%). The patient was treated with three courses of ivermectin (200 µg/kg twice, 2 weeks apart), achieving the parasitological cure. An increase of about 19 times in interleucin (IL)-17 level was observed following the parasitological cure, in addition to a decrease in the white blood cell, eosinophil counts, and IgE levels. This is the first case report, to our knowledge, in which an S. stercoralis adult free-living female was described in human feces and where an increase in IL-17 levels after Strongyloides treatment in a HTLV-1 coinfected individual was observed. This finding raises the need for further studies about IL-17 immunomodulation in S. stercoralis and HTLV-1 coinfected patients.
Figures


Similar articles
-
Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.Parasitol Int. 2017 Feb;66(1):807-812. doi: 10.1016/j.parint.2016.10.004. Epub 2016 Oct 12. Parasitol Int. 2017. PMID: 27744050
-
Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.BMC Infect Dis. 2020 Jul 2;20(1):470. doi: 10.1186/s12879-020-05195-0. BMC Infect Dis. 2020. PMID: 32615937 Free PMC article.
-
[Recurrent strongyloidiasis as an indicator of HTLV-1 infection].Dtsch Med Wochenschr. 2005 Apr 22;130(16):1007-10. doi: 10.1055/s-2005-866778. Dtsch Med Wochenschr. 2005. PMID: 15830313 German.
-
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.Parasite Immunol. 2004 Nov-Dec;26(11-12):487-97. doi: 10.1111/j.0141-9838.2004.00726.x. Parasite Immunol. 2004. PMID: 15771684 Review.
-
[Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].Rev Soc Bras Med Trop. 2002 Nov-Dec;35(6):641-9. doi: 10.1590/s0037-86822002000600016. Epub 2003 Feb 26. Rev Soc Bras Med Trop. 2002. PMID: 12612748 Review. Portuguese.
Cited by
-
A case of disseminated strongyloidiasis diagnosed by worms in the urinary sediment.Parasites Hosts Dis. 2024 May;62(2):238-242. doi: 10.3347/PHD.23124. Epub 2024 May 27. Parasites Hosts Dis. 2024. PMID: 38835264 Free PMC article.
-
Strongyloides stercoralis infection induces gut dysbiosis in chronic kidney disease patients.PLoS Negl Trop Dis. 2022 Sep 6;16(9):e0010302. doi: 10.1371/journal.pntd.0010302. eCollection 2022 Sep. PLoS Negl Trop Dis. 2022. PMID: 36067216 Free PMC article.
-
Evaluation of Strongyloides stercoralis infection in patients with HTLV-1.Biomedica. 2022 Mar 1;42(1):31-40. doi: 10.7705/biomedica.5888. Biomedica. 2022. PMID: 35471168 Free PMC article.
-
Human T-cell Lymphotropic Virus Type 1 (HTLV-1)-Associated Adult T-cell Leukemia/Lymphoma in a Patient Previously Treated for Strongyloidiasis.Cureus. 2023 Oct 18;15(10):e47283. doi: 10.7759/cureus.47283. eCollection 2023 Oct. Cureus. 2023. PMID: 38021878 Free PMC article.
-
Human T-cell Leukemia Virus Type 1 and Strongyloides stercoralis: Partners in Pathogenesis.Pathogens. 2020 Oct 29;9(11):904. doi: 10.3390/pathogens9110904. Pathogens. 2020. PMID: 33137906 Free PMC article. Review.
References
-
- De Souza JN, Machado PR, Teixeira MC, Soares NM, 2014. Recurrence of Strongyloides stercoralis infection in a patient with Hansen’s disease: a case report. Lepr Rev 85: 58–62. - PubMed
-
- Willems L, et al. 2017. Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res 137: 41–48. - PubMed
-
- Carvalho EM, Da Fonseca Porto A, 2004. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 26: 487–497. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical